Zantac Injury Lawsuits
The U.S. Food and Drug Administration issued a recall for all Zantac (ranitidine) drugs including over the counter and prescription formulas on April 1, 2020.
The FDA states that NDMA is a probable carcinogen and warns that people taking these drugs are at a higher risk for developing serious illness including cancer. NDMA is an industrial chemical that is used as a lubricant additive and stabilizer for materials including gasoline and rocket fuel.
Popular over-the-counter brands include:
- Zantac 150 tablets
- Zantac 150 Maximum Strength (and cool mint)
- Zantac 75 tablets
- Wal-Zan 150
- Wal-Zan 75
- Heartburn Relief (ranitidine)
- Acid Reducer (ranitidine)
- Acid Control (ranitidine)
Zantac injury risks
Long-term exposure to Zantac (ranitidine) and associated generic versions can lead to an increased risk for developing cancer including
- Bladder cancer
- Colon or rectal cancer
- Esophageal cancer
- Intestinal cancer
- Kidney cancer
- Liver cancer
- Lung cancer
Zantac cancer lawsuit
If you or someone you know took Zantac (ranitidine) or its generic counterpart and have been diagnosed with cancer, contact us. Our product liability attorneys have represented thousands of people in class action and mass tort lawsuits who were injured by large corporations including those who make dangerous drugs and medical devices over the past 30 years and helped them get compensation for their injuries. We are proud to hold these large companies accountable. Many have been forced to pay back billions of dollars to the people they have injured.
Contact us now for a free, no-obligation case evaluation. You will not pay any legal fees unless and until we recover compensation for you.